تقرير
Primary cutaneous B-cell lymphoma leg type: good response with the RADHAP 21 protocol.
العنوان: | Primary cutaneous B-cell lymphoma leg type: good response with the RADHAP 21 protocol. |
---|---|
المؤلفون: | Pinheiro CG; Dermatology Service, Faculdade de Medicina Nova Esperança, João Pessoa, PB, Brazil. Electronic address: camilagoncalves2@hotmail.com., Cruz LCBD; Dermatology Service, Faculdade de Medicina Nova Esperança, João Pessoa, PB, Brazil; Oncology Service, Hospital Napoleão Laureano, João Pessoa, PB, Brazil., Paz ARD; Dermatology Service, Faculdade de Medicina Nova Esperança, João Pessoa, PB, Brazil; Centro de Diagnóstico Anatomopatológico, João Pessoa, PB, Brazil., Trindade LC; Dermatology Service, Faculdade de Medicina Nova Esperança, João Pessoa, PB, Brazil. |
المصدر: | Anais brasileiros de dermatologia [An Bras Dermatol] 2022 Mar-Apr; Vol. 97 (2), pp. 179-183. Date of Electronic Publication: 2022 Jan 15. |
نوع المنشور: | Case Reports |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier España, S.L Country of Publication: Spain NLM ID: 0067662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1806-4841 (Electronic) Linking ISSN: 03650596 NLM ISO Abbreviation: An Bras Dermatol Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Barcelona, Spain : Elsevier España, S.L. Original Publication: Rio De Janeiro : Sociedade Brasileira de Dermatologia |
مواضيع طبية MeSH: | Lymphoma, B-Cell* , Skin Neoplasms*/pathology, Aged ; Humans ; Leg/pathology ; Male ; Prognosis ; Skin/pathology |
مستخلص: | Primary cutaneous lymphomas are defined as the ones that exclusively affect the skin for up to 6 months after the diagnosis. B-cell lymphomas represent 20-25% of primary cutaneous lymphomas and have, among its subtypes, the leg type, which represents 10 to 20% of cutaneous B-cell lymphomas, generally affecting elderly people and with an intermediate prognosis. This is the report of a rare case of a leg-type B-cell lymphoma with an exuberant clinical presentation affecting a young male patient. (Copyright © 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. All rights reserved.) |
References: | Hippokratia. 2013 Apr;17(2):174-6. (PMID: 24376327) Indian J Med Paediatr Oncol. 2012 Jan;33(1):54-7. (PMID: 22754211) Blood. 2019 Apr 18;133(16):1703-1714. (PMID: 30635287) Proc (Bayl Univ Med Cent). 2011 Oct;24(4):350-3. (PMID: 22046074) Arch Dermatol. 2007 Sep;143(9):1144-50. (PMID: 17875875) An Bras Dermatol. 2011 May-Jun;86(3):549-51. (PMID: 21738974) Cutis. 2018 Sep;102(3):E31-E34. (PMID: 30372723) |
فهرسة مساهمة: | Keywords: Lymphoma; Pharmacological treatment; Radiotherapy; Rituximab; Skin neoplasms |
تواريخ الأحداث: | Date Created: 20220119 Date Completed: 20220316 Latest Revision: 20230916 |
رمز التحديث: | 20230916 |
مُعرف محوري في PubMed: | PMC9073262 |
DOI: | 10.1016/j.abd.2020.09.014 |
PMID: | 35042641 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1806-4841 |
---|---|
DOI: | 10.1016/j.abd.2020.09.014 |